Patent application number | Description | Published |
20110117529 | CPR Competition System - A computer-implemented method for managing rescue training includes registering a plurality of individuals as potential rescue trainees through a central computer server system, receiving from computing devices that are remote from the central server system information indicative of rate and depth of compression for ones of the potential rescue trainees, and generating comparative data that reflects performance of CPR chest compressions for a first rescue trainee against other rescue trainees. The method also includes providing the comparative data over a network for review by one or more of the rescue trainees. | 05-19-2011 |
20110117878 | Community-Based Response System - A computer-implemented method for communicating information to medical responders includes registering a plurality of individuals as potential responders for medical problems, receiving at a central service an indication that a person is having a medical problem and receiving information that identifies a current location of the person, and identifying, from among the registered plurality of individuals, one or more registered individuals who are currently in close proximity to the person having a medical problem. The method also includes transmitting, to the one or more registered individuals, information that identifies the location of the person having a medical problem. The one or more individuals comprise lay responders who are not assigned responsibility to provide lifesaving services in an area around the current location of the person. | 05-19-2011 |
20120016179 | NON-INVASIVE DEVICE FOR SYNCHRONIZING CHEST COMPRESSION AND VENTILATION PARAMETERS TO RESIDUAL MYOCARDIAL ACTIVITY DURING CARDIOPULMONARY RESUSCITATION - A method for improving the cardiac output of a patient who is suffering from pulseless electrical activity or shock and yet still displays some myocardial wall motion including sensing myocardial activity to determine the presence of residual left ventricular pump function having a contraction or ejection phase and a filling or relaxation phase. In such cases, a compressive force is repeatedly applied to the chest based on the sensed myocardial activity such that the compressive force is applied during at least some of the ejection phases and is ceased during at least some of the relaxation phases to permit residual cardiac filling, thereby enhancing cardiac output and organ perfusion. Also incorporated may be a logic circuit capable of utilizing multiple sensing modalities and optimizing the synchronization pattern between multiple phasic therapeutic modalities and myocardial residual mechanical function. | 01-19-2012 |
20120096089 | CURBSYD.TM.: A MOBILE AND WEB-BASED COMMUNITY FOR PROVIDING REAL-TIME, EXPERT CONSULTATION, AND ANSWERS TO SPECIFIC CLINICAL QUESTIONS, USING ARTIFICIAL INTELLIGENCE, AND CROWD-SOURCING TECHNOLOGIES - A smart electronic communications network comprised of clinicians and experts designed for the purpose of answering diagnostic and clinical questions and queries posed by subscribers and participants in of the network. | 04-19-2012 |
20120184882 | Hand Mounted CPR Chest Compression Monitor - A chest compression monitor for measuring the depth of chest compressions achieved during CPR. A displacement detector produces a displacement signal indicative of the displacement of the CPR recipient's chest toward the recipient's spine. A signaling mechanism provides chest compression indication signals prompting a CPR provider to provide a chest compression force at a desired depth and rate. The device is held to the dorsal surface of the hand during use and provides a display for feedback, which is readily visible to the CPR provider. | 07-19-2012 |
Patent application number | Description | Published |
20080230716 | DNA BIOSENSOR AND METHODS FOR MAKING AND USING THE SAME - Disclosed herein are biosensors and methods for making and using the same. In one embodiment, the sensor for detecting an analyte comprises: a substrate, recognition elements specific for the analyte, an excitation source, a detector, a chamber located between the substrate and the excitation source and between the substrate and the detector, and an emission filter. The recognition elements are tethered to the substrate such that the recognition elements can be exposed to a sample. The excitation source is capable of emitting a first light having a first light peak intensity at a first wavelength, wherein the first light can excite a luminophore to emit a second light when the recognition elements interact with the analyte. The detector is capable of detecting the second light emitted by the luminophore. The emission filter is capable of filtering in a band gap that includes the first light peak intensity. | 09-25-2008 |
20080280374 | METHODS AND SYSTEMS FOR DETECTING BIOLOGICAL AND CHEMICAL MATERIALS ON A SUBMICRON STRUCTURED SUBSTRATE - Methods and systems for detecting biological or biochemical analytes generally comprising, a metal film having one or more surfaces comprising one or more submicron structures; a device for applying one or more analytes to at least a portion of the film surface to interact with said metal film; a light source for illuminating a surface of the metal film so that at least some of the light is adapted to be optically altered by the functionalized metal film; and an optical detection subsystem for collecting the optically altered light, wherein the altered light is indicative of surface plasmon resonance on the film, and detecting one or more properties of the analytes based on the collected light. | 11-13-2008 |
20090137058 | CHEMICAL AND BIOLOGICAL DETECTION METHOD AND DEVICE BASED ON MEASUREMENTS OF FLUORESCENCE AND REFLECTIVITY - A device and method for detecting the presence of one or more analytes, bound directly or indirectly to a binding substrate functionalized with a fluorophore, based on measurements of fluorescence and reflectivity. The device and methods comprise an excitation source that emits light capable of being absorbed by a fluorophore and results in the fluorophore's excitation and emission, a fluorescent probe specific for the analyte that is attached via chemisorption to the binding substrate, a detector, and a processor adapted to determine the quantity of the one or more analytes present, by correlating measurements of reflected and fluorescent light. | 05-28-2009 |
20100032582 | FLUORESCENCE DETECTION SYSTEM AND METHOD - A fluorescence detection system comprises a light source configured to produce an excitation light, an optical lens and a fiber bundle. The optical lens is configured to focus the excitation light to a sample to emit fluorescence and to collect the fluorescence. The fiber bundle probe comprises a transmitting fiber configured to transmit the excitation light to the optical lens, and a first receiving fiber configured to deliver the collected fluorescence. The fluorescence detection system further comprises a first detector configured to detect the fluorescence delivered by the receiving fiber to generate a response signal, and a processing unit configured to determine information about the samples by analyzing the response signal. Additionally, a fluorescence detection method is also presented. | 02-11-2010 |
20140356980 | METHOD AND PROCESS TO REDUCE STRESS BASED OVERLAY ERROR - Thermal processing and alignment methods and processes used during fabrication of semiconductor devices are provided. One method includes, for instance: obtaining a device after at least one laser annealing process is completed, the device including a substrate surface and at least one layer over the substrate surface; applying a mask layer to the at least one layer; performing lithography on the mask layer to form a top layer; positioning a first contact-to-gate layer over the top layer; checking alignment of electrical connections between the substrate surface and the first contact-to-gate layer; and determining if an adjustment is needed to at least one parameter of at least one laser annealing beam used during the laser annealing process. In enhanced aspects, the at least one laser annealing process includes: performing three laser anneals; applying three mask layers; and performing lithography three times. | 12-04-2014 |
20140356982 | METHODS FOR OVERLAY IMPROVEMENT THROUGH FEED FORWARD CORRECTION - Methods and processes for establishing a rework threshold for layers applied after thermal processing during fabrication of semiconductor devices are provided. One method includes, for instance: obtaining a device after at least one laser annealing process is completed, the device including a substrate surface and at least one layer over the substrate surface; performing lithography on the at least one layer; positioning a first contact-to-gate layer over the at least one layer; checking alignment of electrical connections between the substrate surface and the first contact-to-gate layer; determining if an overlay error is present; and adjusting at least one subsequent fabrication process pursuant to the overlay error. | 12-04-2014 |
Patent application number | Description | Published |
20100003259 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 01-07-2010 |
20100111953 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-06-2010 |
20100196410 | Streptococcus pneumoniae Antigens and Vaccines - The present invention relates to novel vaccines for the prevention or attenuation of infection by | 08-05-2010 |
20100221287 | Streptococcus pneumoniae Polynucleotides and Sequences - The present invention provides polynucleotide sequences of the genome of | 09-02-2010 |
20110117093 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-19-2011 |
20110293610 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 12-01-2011 |
20120121606 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN - The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. | 05-17-2012 |
Patent application number | Description | Published |
20080229414 | Endpoint enabled for enterprise security assessment sharing - An enterprise-wide sharing arrangement uses a semantic abstraction, called a security assessment, to share security-related information between security products, called endpoints. A security assessment is defined as a tentative assignment by an endpoint of broader contextual meaning to information that is collected about an object of interest. Endpoints utilize an architecture that comprises a common assessment sharing agent and a common assessment generating agent. The common assessment sharing agent is arranged for subscribing to security assessments, publishing security assessments onto a channel, maintaining an awareness of configuration changes on the channel (e.g., when a new endpoint is added or removed), and implementing security features like authorization, authentication and encryption. A common assessment generating engine handles endpoint behavior associated with a security assessment including assessment generation, cancellation, tracking, and rolling-back actions based on assessments that have expired. The common assessment generating engine generates and transmits messages that indicate which local actions are taken. | 09-18-2008 |
20080229421 | Adaptive data collection for root-cause analysis and intrusion detection - Endpoints in an enterprise security environment are configured to adaptively switch from their normal data collection mode to a long-term, detailed data collection mode where advanced analyses are applied to the collected detailed data. Such adaptive data collection and analysis is triggered upon the receipt of a security assessment of a particular type, where a security assessment is defined as a tentative assignment by an endpoint of broader contextual meaning to information (i.e., data in some context) that is collected about an object of interest. A specialized endpoint is coupled to the security assessment channel and performs as a centralized audit point by subscribing to all security assessments, logging the security assessments, and also logging the local actions taken by endpoints in response to detected security incidents in the environment. The specialized endpoint is arranged to perform various analyses and processes on historical security assessments. | 09-18-2008 |
20080229422 | Enterprise security assessment sharing - An enterprise-wide sharing arrangement uses a semantic abstraction, called a security assessment, to share security-related information between different security products, called endpoints. A security assessment is defined as a tentative assignment by an endpoint of broader contextual meaning to information that is collected about an object of interest. Its tentative nature is reflected in two of its components: a fidelity field used to express the level of confidence in the assessment, and a time-to-live field for an estimated time period for which the assessment is valid. Endpoints may publish security assessments onto a security assessment channel, as well as subscribe to a subset of security assessments published by other endpoints. A specialized endpoint is coupled to the channel that performs as a centralized audit point by subscribing to all security assessments, logging the security assessments, and also logging the local actions taken by endpoints in response to security threats. | 09-18-2008 |
20100241974 | Controlling Malicious Activity Detection Using Behavioral Models - Systems, methods, and computer program products are described for controlling malicious activity detection with respect to information technology assets based on behavioral models associated with the respective information technology assets. Protection rules and corresponding sensitivities associated with the behavioral models are applied by protection services to detect malicious activity with respect to the information technology assets. | 09-23-2010 |
20130305374 | CONTROLLING MALICIOUS ACTIVITY DETECTION USING BEHAVIORAL MODELS - Systems, methods, and computer program products are described for controlling malicious activity detection with respect to information technology assets based on behavioral models associated with the respective information technology assets. Protection rules and corresponding sensitivities associated with the behavioral models are applied by protection services to detect malicious activity with respect to the information technology assets. | 11-14-2013 |
20150350230 | CONTROLLING MALICIOUS ACTIVITY DETECTION USING BEHAVIORAL MODELS - Systems, methods, and computer program products are described for controlling malicious activity detection with respect to information technology assets based on behavioral models associated with the respective information technology assets. Protection rules and corresponding sensitivities associated with the behavioral models are applied by protection services to detect malicious activity with respect to the information technology assets. | 12-03-2015 |